- Home
- GNLX vs NMI Comparison
GNLX vs NMI Comparison
Compare GNLX & NMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.57
Company Overview
Basic Information| Metric | GNLX | NMI |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.6M | 114.9M |
| IPO Year | 2022 | 1995 |
Fundamental Metrics
Financial Performance| Metric | GNLX | NMI |
|---|---|---|
| Price | $2.57 | $10.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $19.80 | N/A |
| AVG Volume (30 Days) | ★ 151.5K | 27.7K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.47 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.99 | $9.21 |
| 52 Week High | $8.54 | $10.85 |
Technical Indicators
Market Signals| Indicator | GNLX | NMI |
|---|---|---|
| Relative Strength Index (RSI) | 48.69 | 58.53 |
| Support Level | $2.54 | $9.85 |
| Resistance Level | $3.00 | $10.30 |
| Average True Range (ATR) | 0.16 | 0.16 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 56.00 | 56.52 |
Price Performance
Historical Comparison GNLX
NMI
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About NMI Nuveen Municipal Income Fund Inc.
Nuveen Municipal Income Fund Inc is a diversified, closed-end management investment company. The Fund's investment objective is to provide a high level of current income exempt from federal income tax, which it seeks to achieve by investing mainly in a diversified portfolio of tax-exempt municipal obligations.